Efficacy and Safety of Everolimus As Long-Term Treatment in Japanese Patients With Advanced Pancreatic Neuroendocrine Tumors

被引：0
|
作者：
Lee, Lingaku
Igarashi, Hisato
Hijioka, Masayuki
Ueda, Keijiro
Fujiyama, Takashi
Tachibana, Yuichi
Kawabe, Ken
Ito, Tetsuhide
机构：
来源：
GASTROENTEROLOGY | 2015年 / 148卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa2048
引用
收藏
页码：S393 / S393
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Sunitinib as Long-Term Treatment in Japanese Patients with Advanced Pancreatic Neuroendocrine Tumors
    Lee, L.
    Ueda, K.
    Fujiyama, T.
    Tachibana, Y.
    Yasunaga, K.
    Miki, M.
    Kawabe, K.
    Ito, T.
    NEUROENDOCRINOLOGY, 2016, 103 : 69 - 69
  • [2] Long-Term Everolimus Treatment of Patients with Pancreatic Neuroendocrine Tumors
    Wolin, Edward M.
    CHEMOTHERAPY, 2014, 60 (03) : 143 - 150
  • [3] Efficacy and Safety of Everolimus in Japanese Patients with Advanced Pancreatic Neuroendocrine Tumors (pNET): Japanese Subgroup Analysis of RADIANT-3
    Okusaka, T.
    Ito, T.
    Ikeda, M.
    Tajima, T.
    Kasuga, A.
    Fujita, Y.
    Furuse, J.
    NEUROENDOCRINOLOGY, 2011, 94 : 37 - 38
  • [4] Dose and schedule modification are required for long-term continuation of sunitinib in Japanese patients with advanced pancreatic neuroendocrine tumors
    Lingaku Lee
    Tetsuhide Ito
    Hisato Igarashi
    Masami Miki
    Nao Fujimori
    Ken Kawabe
    Robert T. Jensen
    Yoshihiro Ogawa
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 163 - 169
  • [5] Dose and schedule modification are required for long-term continuation of sunitinib in Japanese patients with advanced pancreatic neuroendocrine tumors
    Lee, Lingaku
    Ito, Tetsuhide
    Igarashi, Hisato
    Miki, Masami
    Fujimori, Nao
    Kawabe, Ken
    Jensen, Robert T.
    Ogawa, Yoshihiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (01) : 163 - 169
  • [6] Everolimus in the treatment of patients with advanced pancreatic neuroendocrine tumors: latest findings and interpretations
    Liu, Eric
    Marincola, Paula
    Oberg, Kjell
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2013, 6 (05) : 412 - 419
  • [7] Safety and Efficacy of Everolimus in Adult Patients with Neuroendocrine Tumors
    Oberstein, Paul E.
    Saif, M. Wasif
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6 : 41 - 51
  • [8] Treatment of advanced pancreatic neuroendocrine tumors: potential role of everolimus
    Cen, Putao
    Amato, Robert J.
    ONCOTARGETS AND THERAPY, 2012, 5 : 217 - 224
  • [9] Everolimus: A New Treatment Option for Advanced Pancreatic Neuroendocrine Tumors
    Thompson, Lisa A.
    Kim, Miryoung
    Wenger, Sarah D.
    O'Bryant, Cindy L.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (09) : 1212 - 1219
  • [10] Impact of everolimus on Japanese patients with advanced pancreatic neuroendocrine neoplasms
    Lee, Lingaku
    Ito, Tetsuhide
    Igarashi, Hisato
    Ueda, Keijiro
    Fujiyama, Takashi
    Kawabe, Ken
    Ogawa, Yoshihiro
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2017, 24 (02) : 95 - 102
12345